SERUM CYSTATIN C FOR RISK STRATIFICATION IN PATIENTS WITH PREDIABETES. Medical science of Uzbekistan, [S. l.], v. 4, n. 3, p. 122–126, 2025. DOI: 10.56121/2181-3612-2025-3-122-126. Disponível em: https://www.fdoctors.uz/index.php/journal/article/view/173. Acesso em: 8 apr. 2026.